1. Home
  2. |Insights
  3. |Corporate Counsel Litigation Forum: A Peer-to-Peer Conversation on Trends in Affirmative Recovery

Corporate Counsel Litigation Forum: A Peer-to-Peer Conversation on Trends in Affirmative Recovery

Webinar | 10.06.15, 10:00 AM EDT - 11:00 AM EDT

This Corporate Counsel Litigation Forum webinar will feature a panel of in-house attorneys who are leaders in affirmative recovery. Panelists will address trends for corporations and institutions to recover overcharges resulting from price-fixing and other antitrust violations, as well as recoveries relating to health care, financial instruments, supply chain, commercial contracts, tax, and international trade.

The panel will engage in discussion and take questions on a range of topics, including:

  • Recent developments and trends for affirmative recovery programs.
  • Class action settlements and opt-out litigation.
  • Portfolio review and development of a pipeline of opportunities.
  • Best practices and lessons learned. 

The panel will be moderated by Crowell & Moring recovery attorneys. Working with these and other in-house affirmative recovery programs, Crowell & Moring has distributed over $1 billion to clients in recent years. Long at the leading edge of recovery and opt-out litigation, Crowell & Moring has been proactively identifying and successfully pursuing recovery opportunities for corporations for more than two decades.

Panelists

  • Daniel Sasse, Crowell & Moring
  • Deborah Arbabi, Crowell & Moring
  • Bill Moore, HP
  • Amy Scholl, Luxottica


For more information, please visit these areas: Corporate and Transactional, Litigation and Trial, Recovery

Participants

Insights

Webinar | 12.10.26

The Third-Party Perspective: Protecting Payors’ Interests in Antitrust Investigations

The Trump administration has sharpened its focus on hospital systems as a key driver of rising health care costs, and the DOJ and FTC are actively patrolling for anticompetitive conduct and mergers that contribute to these rising costs. Managed care organizations are a critical source of evidence in these investigations and are likely to receive Civil Investigative Demands (CIDs), be contacted by agency staff, or may consider proactively engaging with antitrust authorities to address competitive concerns in their markets.

View All Insights